Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Julie Kanter, MD
Researcher Associate Professor
Division of Hematology & Oncology
University of Alabama School of Medicine
1720 2nd Avenue South, NP 2540
Birmingham, Alabama, United States
Dr. Julie Kanter is the Associate Professor of hematology and oncology and Co-Director of the Comprehensive Sickle Cell Center at the University of Alabama at Birmingham. Her academic focus is on improving the comprehensive care of persons with sickle cell disease throughout the lifespan and clinical and translational research to better understand and address issues in treatment and prevention in sickle cell disease.
Prior to moving to Alabama, Dr. Kanter was the Director of sickle cell disease research and Associate Professor of Pediatrics at the Medical University of South Carolina. Dr. Kanter is very committed to improving outcomes in sickle cell disease and ensuring those outcomes reach the affected individuals. She works closely with national partners including the American Society of Hematology and the NIH on both advocacy and research.
Board Certification:
– Pediatrics: Pediatric Hematology-Oncology
Specialties:
– Pediatric Hematology/Oncology
– Cancer
– Pediatric
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events
Related Content
-
Jon Mark Hirshon, MDJon Mark Hirshon, MD, PhD, MPH, FACEP, F...
-
Wake Forest University Sickle Cell Center of ExcellenceWake Forest School of Medicine has serve...
-
Debbie Murray, RN, CPN, CMAC, CHCDebbie Murray is a Certified Nurse Manag...
-
3 Tips about Sickle Cell Disease – Every emergency provider needs to knowChildren and adults with sickle cell dis...
-
Today’s Faces of Sickle Cell Disease: Swee Lay Thein, MB, BS, FRCP, FRCPath, DScSwee Lay Thein was educated in both Mala...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
-
Outcomes of an Emergency Department Observation Unit–Based Pathway for the Treatment of Uncomplicated Vaso-Occlusi...Study objective: This was a prospective...